Abstracts (HTML) List of Authors

Fassbender, T

Frühe Änderung des PSA nach PSMA-Radioligandentherapie als Prädiktor für biochemische Response und Overall Survival

Faust, A

F-18-Markierte Maltotriose für die spezifische PET-Bildgebung bakterieller Infektionen

Fech, V

The influence of digital PET/CT on diagnostic certainty and interrater reliability in 68Ga-PSMA-11 PET/CT for recurrent prostate cancer
The influence of colour scale in lesion detection and patient based sensitivity in Ga-68-PSMA-PET/CT

Feldhaus, F

Evaluation of metabolically active volume in FDG PET/CT for diagnosis of giant cell arteritis in a retrospective study

Feldmann, A

Copper-64/Actinium-225-human anti-PSCA-IgG4 theranostics of a prostate cancer model

Fendler, WP

PET derived biomarkers prognosticate the outcome of NET patients undergoing radiopeptide therapy
PSMA-PET for metastatic hormone-sensitive prostate cancer: A multicenter trial
Intraperitoneal contrast-enhanced small animal FDG PET/CT for improved abdominal delineation and uptake quantification
PSMA- and FDG-PET mismatch assessment for optimized selection of PSMA radioligand therapy candidates
Enhanced PSMA expression in three prostate cancer cell lines after treatment with enzalutamide: implications for Lu-177-PSMA617 radioligand therapy
Alternative application routes for small animal theranostics
Ga-68-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma (HCC)
Early and late FAPI-46 PET acquisition yield near equivalent biodistribution and cancer staging
A comparison of detectability and image quality in Iodine-124 PET across different PET system generations to optimize the protocol for recurrent thyroid cancer patients
Using a Lymphoma and Lung Cancer Trained Neural Network to Predict the Outcome for Breast Cancer on FDG PET/CT Data

Ferdinandus, J

PET derived biomarkers prognosticate the outcome of NET patients undergoing radiopeptide therapy
PSMA-PET for metastatic hormone-sensitive prostate cancer: A multicenter trial
Intraperitoneal contrast-enhanced small animal FDG PET/CT for improved abdominal delineation and uptake quantification
PSMA- and FDG-PET mismatch assessment for optimized selection of PSMA radioligand therapy candidates
Ga-68-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma (HCC)
Early and late FAPI-46 PET acquisition yield near equivalent biodistribution and cancer staging

Fernandez, R

Al[18F]F-NOTA-octreotide: From an emergency solution to the routine tracer – An experience

Feuerecker, B

Prä-therapeutische Dosimetrie von Lu-177-rhPSMA7.3 und Lu-177-PSMA-I&T bei Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom (mCRPC)

Fiedler, R

Evaluation des HET-CAM Modells für Biodistributionsstudien von Nanopartikeln mittels PET und MR Bildgebung

Fietzek, UM

Potential of F-18-PI-2620 Tau PET to Improve the Imaging-Based Diagnosis of Progressive Supranuclear Palsy (PSP)

Fink, GR

Diagnosis of pseudoprogression following lomustine-temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET PET
Hybrid FET PET/MRI radiomics for the non-invasive prediction of the MGMT promoter methylation in brain tumors

Fischer, C

Automatisierte Ein-Topf-Synthese in ethanolischer Reaktionsumgebung und mit präparativer HPLC-Reinigung von F-18-AlF-NOTA-Octreotid für klinische Anwendungen

Fischer, G

Klinische Translation eines modifizierten Y-90-radiomarkierten Anti-CD66-Antikörpers zur Intensivierung der Konditionierung vor allogener hämatopoetischer Stammzelltransplantation
Bestimmung der Radioimmunreaktivität für die Anti-CD66-Antikörpertherapie

Fischer, S

Increased sigma-1 receptor (S1R) availability and its association with depressive and cognitive symptoms in untreated patients with acute early onset unipolar depression (EO-UP): a (-)-F-18-Fluspidine PET study

Fiz, F

18F-FDG PET radiomics predicts pathological data and survival of intrahepatic cholangiocarcinoma
Texture analysis of liver NET liver metastases on Ga-68 DOTATATE PET candidate to PRRT: non-invasive histological and prognostic stratification

Florea, A

Sodium [18F]-Fluoride PET can non-invasively identify calcification as a marker of atherosclerotic plaque vulnerability

Florian, A

PET-MRT zur Charakterisierung von Metabolismus und Fibrose des Myokards bei der Becker-Muskeldystrophie

Flux, GD

Aufbau eines quantitativen SPECT-Bildgebungsnetzwerks für eine europäische multizentrische Dosimetriestudie zur Radioiodbehandlung von Schilddrüsenkarzinomen im Rahmen des MEDIRAD-Projekts

Forgács, A

Impact of multi-pinhole collimators on reader confidence in DAT SPECT

Fostitsch, J

Umkehr des zerebralen No-Reflow-Phänomens nach verlängertem Herzstillstand durch kontrollierte Ganzkörper-Reperfusion: Vorläufige Ergebnisse einer [15O]Wasser PET Studie

Fottner, C

Tumor volumes from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE

Fragoso Costa, P

Enhanced PSMA expression in three prostate cancer cell lines after treatment with enzalutamide: implications for Lu-177-PSMA617 radioligand therapy
Alternative application routes for small animal theranostics
A comparison of detectability and image quality in Iodine-124 PET across different PET system generations to optimize the protocol for recurrent thyroid cancer patients

Franzius, C

Häufigkeit nuklearmedizinischer Untersuchungen in Deutschland

Freesmeyer, M

Standardized Ultrasound Cine Loop Protocol for Benign Thyroid Disease Applied by Medical Technical Assistants
Incidental findings on FDG-PET/CT in HCC patients – relevant information for patients considered for liver transplantation?
Ergänzende Minimal-Activity-PET/CT zur Verifizierung unklarer PET-Befunde - Machbarkeitsanalyse eines Sub-mSv-Protokolls
Reframing multiple reconstructed early dynamic PET images for smooth image rendering
In ovo imaging using ostrich eggs – physiological embryonal development on serial CT scans
Intravenous Lu-177 radionuclide therapies administered with a new versatile shielded application system
In ovo imaging using ostrich eggs – biomagnetism for detection of vitality and embryonal movement during isoflurane anesthesia
Selective internal radioembolization (SIRT) with holmium-166 PLLA microspheres: Distribution of residual activity and outflow dynamics during planning and treatment procedures

Frielink, C

Validation of exendin for beta cell imaging: ex vivo autoradiography of human pancreas demonstrates specific accumulation of radiolabeled exendin in islets of Langerhans

Frings, L

Altered regional cerebral glucose metabolism and its correlation with cognitive impairment in the subacute stage of COVID-19
Regionale Signatur des Normaldruckhydrozephalus in der [18F]FDG-PET
Asymmetry of metabolism in the auditory cortex predicts the outcome of cochlear implantation

Frost, N

FDG-PET/CT für das prätherapeutische Lymphknotenstaging beim nicht-kleinzelligen Lungenkarzinom: Ein Vorschlag für modifizierte Leitlinienempfehlungen

Frumkin, D

Ein optimiertes Bildgebungsprotokoll für die Tc-99m-DPD Szintigraphie und SPECT/CT-Quantifizierung bei kardialer Transthyretin (TTR)-Amyloidose

Fuchs, M

PET-based response assessment in Hodgkin lymphoma patients undergoing PD-1 blockade: data of the German Hodgkin Study Group NIVAHL trial for early unfavorable stages

Fulton, R

A data driven motion compensation for head movement in CT for hybrid PET/CT brain scan: A phantom and patient study

Fundke, R

Häufigkeit nuklearmedizinischer Untersuchungen in Deutschland

Fürstner, M

The CCK-2 receptor agonist Lu-177-PP-F11N for PRRT of medullary thyroid cancer – Recent results of the phase 1 “LUMED” Study
PBPK-based in silico tumor microenvironment model for 177Lu-PSMA-617 therapy
NEMA NU 2-2018 performance measurements of Biograph Vision Quadra PET/CT system
Pharmacokinetics of PSMA-617 – dynamics of radiopharmaceutical uptake in tumours

Furth, C

The prognostic value of the De Ritis ratio on progression free survival in patients with NET undergoing [177Lu]Lu-DOTATOC-PRRT: A retrospective analysis
Evaluation of metabolically active volume in FDG PET/CT for diagnosis of giant cell arteritis in a retrospective study
FDG-PET/CT für das prätherapeutische Lymphknotenstaging beim nicht-kleinzelligen Lungenkarzinom: Ein Vorschlag für modifizierte Leitlinienempfehlungen
Ambulante vs. stationäre Patientenvorbereitung zur FDG-PET/CT und PET/MRT bei kardialen Fragestellungen